VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 965 · 116th Congress

CREATES Act of 2019

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

DCD CicillineSponsor
68 cosponsors · 55 D, 13 R
DCR Collins DMR McKinley JND Nadler FSR Sensenbrenner PWD Welch MMR Meadows AFD Finkenauer TCR Cole LDD Doggett MGR Gallagher DLD Lipinski BMD McCollum BRD Rush DDD Dingell FPD Pallone SPR Perry RRD Ruiz ACD Craig AED Eshoo DMD Matsui LGR Gohmert PTD Tonko JVD Van Drew YCD Clarke CAD Allred JCD Courtney JCD Crow AGR Gonzalez JSD Schakowsky JLD Larson BMD McAdams KSD Schrader RDR Davis SDD Davids JKD Kennedy DND Norcross CPD Pappas ASD Spanberger MQD Quigley JCD Cooper TDD Deutch JLD Langevin LMD McBath DMD Mucarsel-Powell JRD Raskin GSD Stanton SCD Cohen JJR Jordan SWD Wild AKD Kim ECD Case SCD Casten CHD Houlahan DJR Joyce RKD Khanna RNR Norman CPD Pingree DSD Scott KSD Schrier SCD Carbajal ASD Smith JWD Wexton GCD Connolly GCD Cisneros CBD Bustos SGD Garcia GMD Meng LUD Underwood

5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019

What it does: CRS summary · Reported to House, Part II · May 10, 2019

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019

This bill generally allows the developer of a drug or biological product, such as a generic or biosimilar version of a drug, to bring a civil action against the license holder of an approved medication if the holder refuses to make available sufficient quantities of the approved medication for the developer's testing. The bill also establishes affirmative defenses to such a civil action.

In addition, the bill authorizes drug manufacturers seeking Food and Drug Administration approval for a generic drug to use alternative methods to develop elements assure safe use of a drug.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: CREATES Act of 2019

Also known as: Creating and Restoring Equal Access to Equivalent Samples Act of 2019

Latest action (May 16, 2019): Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.

Policy area: Health · Origin: House · Introduced: Feb 5, 2019

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.